---
title: "Nano-X Imaging (NNOX) stock: news and investor profile"
url: "https://aibio.space/companies/nano-x-imaging/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "Nano-X Imaging Ltd. (NASDAQ: NNOX), United States. Listing facts, related biotech companies and news on aibio.space."
---

NNOX Nano-X Imaging Ltd. NASDAQ · United States

# Nano-X Imaging (NNOX) news

Nano-X Imaging Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NNOX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest Nano-X Imaging news

We have not published a story on Nano-X Imaging yet. When there is news, it will appear here.

## Nano-X Imaging at a glance

- **Ticker**: NNOX

- **Listing**: NASDAQ

- **Country**: United States

- **Cash, Dec 31, 2025**: $49.2 million

### Related companies

- [INTERPACE BIOSCIENCES, INC.](https://aibio.space/companies/interpace-biosciences/) OTC: IDXG
- [CYPHERPUNK TECHNOLOGIES INC.](https://aibio.space/companies/cypherpunk-technologies/) NASDAQ: CYPH
- [Alphatec Holdings](https://aibio.space/companies/alphatec/) NASDAQ: ATEC
- [First Choice Healthcare Solutions](https://aibio.space/companies/first-choice-healthcare-solutions/) OTC: FCHS
- [NEUROONE MEDICAL TECHNOLOGIES](https://aibio.space/companies/neuroone-medical-technologies/) NASDAQ: NMTC
- [IRADIMED CORP](https://aibio.space/companies/iradimed/) NASDAQ: IRMD
- [ESCALON MEDICAL CORP](https://aibio.space/companies/escalon-medical/) OTC: ESMC
- [OPKO HEALTH, INC.](https://aibio.space/companies/opko-health/) NASDAQ: OPK

### Also on NASDAQ

- [BullFrog AI Holdings](https://aibio.space/companies/bullfrog-ai/) BFRG
- [Kymera Therapeutics](https://aibio.space/companies/kymera-therapeutics/) KYMR
- [Ovid Therapeutics](https://aibio.space/companies/ovid-therapeutics/) OVID
- [Climb Bio](https://aibio.space/companies/climb-bio/) CLYM
- [INVO Fertility](https://aibio.space/companies/invo-fertility/) IVF
- [MindWalk Holdings](https://aibio.space/companies/mindwalk/) HYFT

## Nano-X Imaging annual financials

| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | [$13.0 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) | [$11.3 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) |
| Research and development | [$19.2 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) | [$20.2 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) |
| Net income (loss) | [-$75.0 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) | [-$53.5 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) |
| Cash from operations | [-$40.8 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) | [-$36.6 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) |
| Cash and equivalents | [$49.2 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) | [$39.3 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) |
| Short-term investments |  | [$18.4 million](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/) |

Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents $49.2 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Nano-X Imaging

What is the ticker symbol of Nano-X Imaging?

Nano-X Imaging Ltd. trades under the ticker NNOX on NASDAQ.

Where is Nano-X Imaging listed?

Nano-X Imaging Ltd. is listed on NASDAQ.

Which country or territory is Nano-X Imaging listed under?

Our directory records Nano-X Imaging Ltd. under United States.

Does aibio.space cover Nano-X Imaging?

aibio.space lists Nano-X Imaging Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

What was Nano-X Imaging's revenue last year?

$13.0 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Nano-X Imaging profitable?

Nano-X Imaging Ltd. reported a net loss of $75.0 million for the fiscal year ended Dec 31, 2025, and used $40.8 million of cash in operations, per its annual report to the SEC.

How much does Nano-X Imaging spend on research and development?

$19.2 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Nano-X Imaging have?

$49.2 million in cash at Dec 31, 2025, per its 20-F.

## Investor discussion: Nano-X Imaging

Members talk about Nano-X Imaging (NNOX). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Nano-X Imaging, newest first. Each line links the filing it comes from.

1. 2026-10-28 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1795251/000121390026113380/ea030999302ex99-1.htm)
2. 2026-10-02 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1795251/000121390026106460/ea0307363-6k_nanox.htm)
3. 2026-09-17 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1795251/000121390026100989/ea030586501ex99-1.htm)
4. 2026-09-09 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1795251/000121390026098227/ea030482601ex99-1.htm)
5. 2026-08-07 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1795251/000121390026086443/ea0301013-424b5_nanoximag.htm)
6. 2026-08-06 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1795251/000121390026085920/ea030088201ex99-1.htm)
7. 2026-07-24 Financings Set up an at-the-market program to sell shares over time. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1795251/000121390026081046/ea0298678-424b5_nanoximag.htm)
8. 2026-04-30 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 20-F. [Source](https://www.sec.gov/Archives/edgar/data/1795251/000121390026050191/ea0282652-20f_nanox.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:NNOX on TradingView](https://www.tradingview.com/symbols/NASDAQ-NNOX/).

## Listing details

Nano-X Imaging Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NNOX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Nano-X Imaging Ltd.

- **Ticker**: NNOX

- **Listing**: NASDAQ

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/nano-x-imaging/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Nano-X Imaging (NNOX) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/nano-x-imaging/